Sanara MedTech (SMTI) Net Cash Flow (2010 - 2026)

Sanara MedTech has reported Net Cash Flow for 16 years, with the latest figure at -$3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 162.05% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$7.1 million (down 139.72% YoY), and the FY2025 full-year result was $700562.0, down 93.47% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$3.0 million, down from $1.6 million in the prior quarter.
• The five-year high for Net Cash Flow was $10.1 million in Q3 2024, with the low at -$3.7 million in Q2 2025.
• Historically, Net Cash Flow has averaged -$297551.9 across 5 years, with a median of -$1.3 million in 2022.
• Annual changes were most pronounced in 2024 — Net Cash Flow surged 5664.22% — and 2025, when it sank 212.25%.
• Sanara MedTech's Net Cash Flow stood at -$1.3 million in 2022, then advanced by 17.92% to -$1.1 million in 2023, then surged by 63.36% to -$398894.0 in 2024, then jumped by 510.94% to $1.6 million in 2025, then plunged by 282.06% to -$3.0 million in 2026.
• The last three Net Cash Flow figures came in at -$3.0 million (Q1 2026), $1.6 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.